| ¿µ¹® | interstitial therapy | ÇÑ±Û | ±ÙÁ¢Ä¡·á |
|---|---|---|---|
| ¼³¸í | ÁÖ·Î Á¾¾çÀÇ Ä¡·á¸¦ ¸ñÀûÀ¸·Î ÇÏ¿© ÀÎü Á¶Á÷³»¿¡ ¹æ»ç¼± ¹°ÁúÀ» »ðÀÔÇÏ¿© ¹æ»ç¼±À» Á¶»çÇÏ´Â Ä¡·á¹ýÀÌ´Ù. Brachytherapy¶ó°íµµ ÇÑ´Ù. |
||
| ¿µ¹® | cystic fibrosis | ÇÑ±Û | ³¶¼º¼¶À¯Áõ |
|---|---|---|---|
| ¼³¸í | À¯Àüº´ÀÇ Çϳª·Î ¶¡»ù, ±â°üÁö¿¡¼ Á¡¾×À» ºÐºñÇÏ´Â »ù, ÀÌÀÚµîÀÇ ¿ÜºÐºñ»ù(¸ö ¹ÛÀ¸·Î ¾×ü¸¦ ºÐºñÇÏ´Â »ù. ³»ºÐºñ»ùÀ» Á¦¿ÜÇÑ ¸ðµç »ùÀ» À̸¥´Ù)ÀÇ ÀÌ»óÀ» Ư¡À¸·Î ÇÏ´Â º´ÀÌ´Ù. Áß¿äÇÑ º´ÀûÀÎ º¯È´Â ÁÖ·Î ±â°üÁö¿¡¼ Á¡¾×À» ºÐºñÇÏ´Â ºÐºñ»ù¿¡¼ Áö³ªÄ¡°Ô Á¡µµ°¡ ³ôÀº Á¡¾×ÀÌ ºÐºñµÇ¾î ±â°üÁö¸¦ ¸·¾Æ È£ÈíÀå¾Ö¸¦ ÀÏÀ¸Å°´Â ÆóÀÇ º´ÅÍÀ̸ç, ¶¡¿¡¼ °úµµÇÑ ÀüÇØÁú ƯÈ÷ ¿°È³ªÆ®·ý(NaCl)ÀÌ ºÐºñµÇ¾î ¸ö¿¡ ÀüÇØÁúÀÌ ºÎÁ·ÇÏ°Ô µÈ´Ù. ¶Ç ÀÌÀÚÀÇ ¼ÒȾ×À» ºÐºñÇÏ´Â ºÐºñ»ùÀÇ ÀÌ»óÀ¸·Î ÀÌÀÚ°üÀÌ ¸·È÷°Å³ª ÀÌÀÚÀÇ ±â´ÉÀÌ ¶³¾îÁ®¼ ¼ÒÈÀÇ Àå¾Ö¸¦ ÀÏÀ¸Å°±âµµ ÇÑ´Ù. À¯Å°迡 ¸¹À¸¸ç ¿ì¸®³ª¶ó¿¡´Â ¾ÆÁÖ µå¹°´Ù. |
||
| ¿µ¹® | fibrosis | ÇÑ±Û | ¼¶À¯Áõ, ¼¶À¯È |
|---|---|---|---|
| ¼³¸í | ¾Æ±³Áú¼¶À¯¸¦ Çü¼ºÇÏ´Â ¼¶À¯Á¶Á÷ÀÇ Áõ½ÄÀ¸·Î ¸öÀÇ ½ÇÁú¼¼Æ÷ÀÇ ±«»ç³ª ¼Õ»ó¿¡ ÀÌ¾î¼ ³ªÅ¸³ª´Â °æ¿ì°¡ º¸ÅëÀÌ´Ù. µÎ ´Ü°è, Áï ¼Õ»óºÎÀ§¿¡¼ ¼¶À¯¸ð¼¼Æ÷ÀÇ ÀÌÁÖ¿Í Áõ½Ä, ±×¸®°í ¼¶À¯¸ð¼¼Æ÷¿¡ ÀÇÇÑ ¼¼Æ÷ÀÇ ¹ÙÅÁÁú ÃàÀûÀ¸·Î ÁøÇàµÈ´Ù. ÇǺÎÀÇ °æ¿ì ÁøÇdz» ¼¶À¯¸ð¼¼Æ÷ÀÇ Áõ½Ä°ú ¾Æ±³Áú ¼¶À¯ÀÇ Áõ½ÄÀÌ ÀÖ´Â °æ¿ì¸¦ ¼¶À¯È, °ÅÀÇ ¾Æ±³Áú ¼¶À¯·Î¸¸ ±¸¼ºµÇ´Â °æ¿ì¸¦ °æÈ¶ó°í ÇÑ´Ù. |
||
| ¿µ¹® | nephritis(interstitial) | ÇÑ±Û | ÄáÆÏ¿°, ½ÅÀå¿°(°£Áú¼º) |
|---|---|---|---|
| ¼³¸í | ÄáÆÏ»çÀÌÁú(renal interstitium: ÄáÆÏÀÇ ¼¼´¢°ü »çÀÌÀÇ °áÇÕÁ¶Á÷)ÀÇ ¿°Áõ. ±Þ¼ºÀ¸·Î ÀϾ´Â °£ÁúÄáÆÏ¿°Àº ´ë°³ ¸¹Àº ¾àÀ» º¹¿ëÇÑ ÈÄ¿¡ ¹ß»ýÇÏ´Â µ¥, ¿, ÇǺÎÀÇ º¯»ö, Ç÷¾×³»ÀÇ È£»ê±¸Áõ ±×¸®°í ¼Òº¯ÀÇ °¨¼Ò¿Í ÄáÆÏ±â´ÉÀÇ °¨¼Ò¸¦ Ư¡À¸·Î ÇÑ´Ù. Ä¡·á´Â º¹¿ëÁßÀÎ ¾àÀ» ²÷°í, ºÎ½Å°ÑÁúÈ£¸£¸óÁ¦¸¦ Åõ¿©ÇÑ´Ù. ÄáÆÏÀº °¢Á¾ ³ëÆó¹°, ÀüÇØÁú, ¼öºÐ µîÀ» Æ÷ÇÔÇÑ ¿ä¸¦ »ý»êÇÏ¿© ¹èÃâÇÏ´Â µ¿½Ã¿¡ ¼ö¼ÒÀÌ¿Â, ³ªÆ®·ý, Ä®·ý, Àλê À̿ ³óµµ µîÀ» Á¶ÀýÇÏ¸ç ³»ºÐºñ¿Í ¿ÜºÐºñ ±â´É¿¡ °ü¿©Çϱ⵵ ÇÑ´Ù. |
||
| ¿µ¹® | chronic obstructive pulmonary disease | ÇÑ±Û | ¸¸¼ºÆó¼âÆóº´ |
|---|---|---|---|
| ¼³¸í | ¸¸¼ºÀûÀ¸·Î ±âµµÀÇ Æó¼â¸¦ °¡Á®¿À´Â º´À» À̸£´Â ¸». ´ë°³ ¸¸¼º±â°üÁö¿°, ±â°üÁö õ½Ä, Æó±âÁ¾ÀÇ 3°¡Áö º´À» ¸»ÇÑ´Ù. ¸¸¼º±â°üÁö¿°À̶õ ±â°üÁöÀÇ ¸¸¼º¿°ÁõÀ» ¸»ÇÑ´Ù. ±â°üÁöÀÇ ¿°ÁõÀ¸·Î ÀÎÇØ¼ ±â°üÁöÀÇ Á¡¸·¿¡ ºÎÁ¾ÀÌ »ý±â°í ÀÌ·Î ÀÎÇØ¼ ±â°üÁöÀÇ ³»°æÀÌ Á¼¾ÆÁ®¼ ±âµµÀÇ Æó¼â¸¦ °¡Á®¿Â´Ù. ´ë°³ Èí¿¬°ú ¹ÐÁ¢ÇÑ ¿¬°üÀ» °¡Áö¸ç, È£Èí°ï¶õ, ±âħ, ±×¸®°í °¡·¡(´ë°³ »öÀÌ Çª¸£°í Á¡µµ°¡ ³ôÀº °¡·¡)°¡ Áõ»óÀ¸·Î ³ªÅ¸³´Ù. Æó±âÁ¾Àº ±â°üÁöÀÇ º®À» ÁöÁöÇÏ´Â Á¶Á÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼ ±â°üÁö°¡ Á¦ ¸ð¾çÀ» °®ÃßÁö ¸øÇÏ°í ¹«³ÊÁö°Ô µÇ¾î ±âµµÀÇ Æó¼â°¡ ÀϾ´Â º´ÀÌ´Ù. Áï ±â°üÁö°¡ °ü ¸ð¾çÀ¸·Î ÆØÆØÇÏ°Ô ÆìÁö´Â °ÍÀ» ÁöÁöÇÏ´Â Á¶Á÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼ °ü¸ð¾çÀ¸·Î ÆìÁöÁö ¸øÇØ °á±¹Àº ÆóÆ÷³»¿¡ °ø±â°¡ Â÷°í ÆóÆ÷º®ÀÌ ÆÄ¿µÇ°í ±â°üÁö°¡ Á¼¾ÆÁö°Ô µÇ´Â º´À» ¸»ÇÑ´Ù. ±â°üÁöõ½ÄÀ̶õ ¿©·¯ °¡Áö Àڱؿ¡ ´ëÇØ¼ ±â°üÁö°¡ °ú¹ÎÇÑ ¹ÝÀÀÀ» º¸¿©¼ »ý±â´Â ±â°üÁöÀÇ °¡¿ªÀûÀÎ Æó¼â¸¦ ÀǹÌÇÑ´Ù. Áï Á¤»óÀο¡°Ô¼´Â ±â°üÁöÀÇ Æó¼â¸¦ º¸ÀÌÁö ¾Ê´Â Àڱؿ¡ ´ëÇØ¼ ±â°üÁöÀÇ Æó¼â°¡ »ý±â°í ±× ÀÚ±ØÀÌ ¾øÀ» °æ¿ì¿¡´Â ±â°üÁöÀÇ Æó¼â°¡ ¾ø¾îÁö´Â º´À» ¸»ÇÑ´Ù. |
||
| IPF | idiopathic pulmonary fibrosis; infection-potentiating factor; interstitial pulmonary fibrosis |
|---|---|
| MF | 1) Myelo-Fibrosis = Agnogenic Myeloid Metaplasia with Myelo-F... |
| CFF | critical flicker fusion [test]; critical fusion frequency; cystic fibrosis factor; Cystic Fibrosis F... |
| CFP | chronic false positive; Clinical Fellowship Program; cyclophosphamide, fluorouracil, prednisone; cys... |
| JVP | [POMD P 49 - 52] 1) Jugular Vein Pressure 2) Jugular Venous Pulse ... |
| IPF | Interstitial pulmonary fibrosis |
|---|---|
| IF | interstitial fibrosis |
| IPF | Idiopathic pulmonary fibrosis |
| PF | Pulmonary Fibrosis |
| PIE | Pulmonary interstitial emphysema |
pulmonary pleura
| interstitial pulmonary fibrosis | <radiology> Idiopathic, idiopathic pulmonary fibrosis (AKA: usual interstitial pneumonitis), Hamman-Rich syndrome (rapidly progressive), drug-related, collagen-vascular disease, rheumatoid lung disease, scleroderma (12 Dec 1998) |
|---|
| diffuse interstitial pulmonary fibrosis | This represents a group of pulmonary disorders (lower respiratory tract) that leads to a functional loss in the alveolar air sacs and a compromise in the diffusion of oxygen from air to blood. There is widespread inflammation and scar tissue (fibrosis) formation within the lung. The causes are varied and include: inorganic and organic dusts, gases, fumes, vapors, infections, radiation, medications, coal dust, silicosis and byssinosis. When the cause is not identifiable it is referred to as idiopathic diffuse interstitial pulmonary fibrosis (27 Sep 1997) |
|---|---|
| diffuse interstitial fibrosis | Progressive fibrous changes and scarring within the lung tissue, eventually interfering with normal gas exchange. (27 Sep 1997) |
| idiopathic interstitial fibrosis | A progressive inflammatory condition starting with diffuse alveolar damage and resulting in fibrosis and honeycombing over a variable time period; also a common feature of collagen-vascular diseases. Synonym: fibrosing alveolitis, Hamman-Rich syndrome, idiopathic interstitial fibrosis. (05 Mar 2000) |
| pulmonary fibrosis | Chronic inflammation and progressive fibrosis of the pulmonary alveolar walls, with steadily progressive dyspnea, resulting finally in death from oxygen lack or right heart failure. (12 Dec 1998) |
| idiopathic pulmonary fibrosis | <radiology> Aka: usual interstitial pneumonia (UIP), 5-6th decade; M:F = 1:1, clubbing of fingers (83%), lymphocytosis on lavage, increased occurence of bronchogenic CA, average survival of 4-6 years; 87% mortality CXR findings: occasional ground glass pattern in early stage of alveolitis, diffuse reticulations (60%) predominantly at bases, honeycombing, pleural effusion (4%); pleural thickening (6%), pneumothorax in 7% (late stage), progressive volume loss see: interstitial pulmonary fibrosis (12 Dec 1998) |
| African endomyocardial fibrosis | Fibrosis of the inner layers of the myocardium, often including the endocardium, causing diastolic restriction of the heart; indigenous to East Africa. (05 Mar 2000) |
| radiation fibrosis | The formation of scar tissue as a result of radiation therapy to the lung. (12 Dec 1998) |
| mediastinal fibrosis | <radiology> Histoplasmosis most common cause, can cause superior vena cava obstruction (12 Dec 1998) |
| replacement fibrosis | The formation of fibrous tissue that occupies sites where various other cells and tissues have become atrophied, or degenerated and necrotic. (05 Mar 2000) |
| retroperitoneal fibrosis | <radiology> Ureters tapered or obstructed, most severe at L4-5, ureters deviated medially, Treatment: symptomatic; steroids have ? long-term benefit Differential diagnosis: malignancy, lymphoma (especially Hodgkin's), metastasis from colon and breast, retroperitoneal sarcoma, drugs, methysergide (Sansert), haemorrhage, aortic aneurysm, trauma or surgery, inflammation, Crohn's disease, diverticulitis, pancreatitis, extravasated urine, radiation (12 Dec 1998) |
| pericentral fibrosis | Fibrosis occurring around the central veins in the hepatic lobules. (05 Mar 2000) |
| perimuscular fibrosis | Fibrosis in the outer media of arteries, usually the renal arteries of young women, where it causes segmental stenosis and hypertension; a variety of fibromuscular dysplasia. Synonym: subadventitial fibrosis. (05 Mar 2000) |
| pipestem fibrosis | A characteristic pipe-shaped fibrosis formed around hepatic portal veins in some cases of long-continued heavy infection with Schistosoma mansoni; thought to be induced by the presence of large numbers of schistosome eggs in the hepatic tissues. Synonym: Symmers' clay pipestem fibrosis, Symmers' fibrosis. (05 Mar 2000) |
| congenital fibrosis of the extraocular muscles | An autosomal dominant disorder associated with blepharoptosis and absence of eye movements. (05 Mar 2000) |
| cystic fibrosis | <chest medicine> A generalised disorder of infants, children and young adults, in which there is widespread dysfunction of the exocrine glands, characterised by signs of chronic pulmonary disease (due to excess mucus production in the respiratory tract), pancreatic deficiency, abnormally high levels of electrolytes in the sweat and occasionally by biliary cirrhosis. There is an ineffective immunologic defense against bacteria in the lungs. Pathologically, the pancreas shows obstruction of the pancreatic ducts by amorphous eosinophilic concretions, with consequent deficiency of pancreatic enzymes, resulting in steatorrhoea and azotorrhoea and intestinal malabsorption. The degree of involvement of organs and glandular systems may vary greatly, with consequent variations in the clinical picture. Inheritance: autosomal recessive. (13 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|